Because HER3 has a strong tendency to form heterodimers with HER2, ErbB2/ErbB3 heterodimer can promote HNSCC cell growth and increase resistance to EGFR TKI gefitinib[29]. This evidence concerns the gene ERBB3 and head and neck squamous cell carcinoma.